COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 573

Emailed: 0

PDF Downloaded: 175

Indian Journal of Clinical Anaesthesia


Etomidate versus Propofol as induction agent in patients undergoing Endoscopic Retrograde Cholangiopancreaticogram (ERCP)


Full Text PDF Share on Facebook Share on Twitter


Author Details : Swati Bisht, Sadanand Gopal

Volume : 4, Issue : 1, Year : 2017

Article Page : 122-127


Suggest article by email

Abstract

Background: Endoscopic retrograde pancreaticogram (ERCP) requires patient to be sedated and pain free in prone position. Propofol sedation may cause cardiorespiratory depression. Etomidate is a good alternative with stable hemodynamic and respiratory parameters. We have compared these two drugs on their cardiorespiratory, induction time and recovery profiles.
Methods: A total of 100 patients undergoing ERCP were randomly distributed to etomidate or propofol groups. Patients in the etomidate group received etomidate induction and maintenance, while propofol group received propofol anaesthesia. Cardiorespiratory parameters, time for induction and recovery along with adverse effects were noted.
Results: The induction time was longer in the etomidate group than the propofol group.(p<0.001) The time for attaining Modified Aldrette score 9 was longer in the etomidate group(p<0.001). The percentage of fall in MAP and HR was higher in propofol group(p<0.001). SpO2 fall was also significant in propofol group. One patient in etomidate group developed myoclonus. Adverse effects like bradycardia, hypotension, hypoxia were significantly more in the propofol group. Conclusion: Etomidate is a safe and cardiostable induction agent in patients with obstructive jaundice undergoing ERCP.

Keywords:
Etomidate, Propofol, ERCP, Modified aldrette score 

How to cite : Bisht S, Gopal S, Etomidate versus Propofol as induction agent in patients undergoing Endoscopic Retrograde Cholangiopancreaticogram (ERCP). Indian J Clin Anaesth 2017;4(1):122-127

Copyright © 2017 by author(s) and Indian J Clin Anaesth. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)